Debt-to-equity of AMICUS THERAPEUTICS, INC. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AMICUS THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • AMICUS THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 296%, a 27% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AMICUS THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 296% -108% -27% 30 Sep 2025
Q2 2025 312% -129% -29% 30 Jun 2025
Q1 2025 345% -114% -25% 31 Mar 2025
Q4 2024 378% -107% -22% 31 Dec 2024
Q3 2024 404% -116% -22% 30 Sep 2024
Q2 2024 441% -79% -15% 30 Jun 2024
Q1 2024 459% -3% -0.56% 31 Mar 2024
Q4 2023 486% +120% +33% 31 Dec 2023
Q3 2023 520% +234% +82% 30 Sep 2023
Q2 2023 520% +302% +138% 30 Jun 2023
Q1 2023 461% +256% +124% 31 Mar 2023
Q4 2022 366% +165% +82% 31 Dec 2022
Q3 2022 286% +81% +40% 30 Sep 2022
Q2 2022 218% +3% +1.2% 30 Jun 2022
Q1 2022 206% +35% +21% 31 Mar 2022
Q4 2021 201% +66% +48% 31 Dec 2021
Q3 2021 205% +101% +96% 30 Sep 2021
Q2 2021 216% +138% +179% 30 Jun 2021
Q1 2021 171% +104% +154% 31 Mar 2021
Q4 2020 136% +71% +110% 31 Dec 2020
Q3 2020 104% +32% +44% 30 Sep 2020
Q2 2020 77% -6% -7.2% 30 Jun 2020
Q1 2020 67% -15% -18% 31 Mar 2020
Q4 2019 64% -16% -20% 31 Dec 2019
Q3 2019 73% +2% +2.2% 30 Sep 2019
Q2 2019 83% 30 Jun 2019
Q1 2019 82% 31 Mar 2019
Q4 2018 81% 31 Dec 2018
Q3 2018 71% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.